Видео ютуба по тегу Vnrx Analysis

VolitionRx (VNRX|$64.6M) - 2025 Q2 Earnings Analysis
VolitionRx (VNRX|$64.6M) - 2025 Q2 Earnings Analysis
VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with IDEXX Laboratories
VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with IDEXX Laboratories
VolitionRx 8-K: My Insight on This Underwriting Amendment
VolitionRx 8-K: My Insight on This Underwriting Amendment
You Need To Pay Attention To Volition Stock NYSE: VNRX
You Need To Pay Attention To Volition Stock NYSE: VNRX
Investing $25/Month in VOLITION RX $VNRX stocks since 2015? #stockmarket #trading #money
Investing $25/Month in VOLITION RX $VNRX stocks since 2015? #stockmarket #trading #money
Revolutionizing the Diagnosis of Life-altering Diseases 為重疾診斷技術帶來革命性突破 | VolitionRx (NYSE-A: VNRX)
Revolutionizing the Diagnosis of Life-altering Diseases 為重疾診斷技術帶來革命性突破 | VolitionRx (NYSE-A: VNRX)
VolitionRx Limited - VNRX Stock Chart Technical Analysis for 09-25-2019
VolitionRx Limited - VNRX Stock Chart Technical Analysis for 09-25-2019
Healthcare Stock to Watch Now | Top Health Stock News Today | VolitionRx Limited | VNRX
Healthcare Stock to Watch Now | Top Health Stock News Today | VolitionRx Limited | VNRX
VolitionRx Limited - VNRX Stock Chart Technical Analysis for 09-24-2019
VolitionRx Limited - VNRX Stock Chart Technical Analysis for 09-24-2019
Cameron Reynolds - Volition RX
Cameron Reynolds - Volition RX
Rethinking the approach to diagnose cancer: VolitionRx Limited (NYSE AMERICAN: VNRX) 重塑癌症診斷方法
Rethinking the approach to diagnose cancer: VolitionRx Limited (NYSE AMERICAN: VNRX) 重塑癌症診斷方法
Revolutionizing Cancer Diagnostics | VolitionRx (NYSE AMERICAN: VNRX) Presentation at GCFF (Sep 10)
Revolutionizing Cancer Diagnostics | VolitionRx (NYSE AMERICAN: VNRX) Presentation at GCFF (Sep 10)
Volition (VNRX) NobleCon18 Presentation Replay
Volition (VNRX) NobleCon18 Presentation Replay
🔴 VolitionRX Ltd VNRX Stock Trading Facts 🔴
🔴 VolitionRX Ltd VNRX Stock Trading Facts 🔴
VolitionRx Ltd. (NYSE MKT: VNRX) Webcast | SNN Network
VolitionRx Ltd. (NYSE MKT: VNRX) Webcast | SNN Network
VolitionRX (VNRX) - Cameron Reynolds, President & CEO
VolitionRX (VNRX) - Cameron Reynolds, President & CEO
VolitionRx (VNRX) - Cameron Reynolds President & CEO
VolitionRx (VNRX) - Cameron Reynolds President & CEO
VolitionRx - 2024 Q3 Earnings Analysis
VolitionRx - 2024 Q3 Earnings Analysis
VolitionRx Discusses Promising Clinical Trials Results for its Novel COVID-19 Triage Test
VolitionRx Discusses Promising Clinical Trials Results for its Novel COVID-19 Triage Test
VolitionRx Shares: Decoding the Fine Print & Investor Impact
VolitionRx Shares: Decoding the Fine Print & Investor Impact
VolitionRx Provides Update on Animal Health Blood Test Program, Licensing Deals and Focus for 2021
VolitionRx Provides Update on Animal Health Blood Test Program, Licensing Deals and Focus for 2021